Euphrasia Officinalis.

From $9.95 / bottle(s)
Inc GST
Delivery Estimator Please select a version. Delivery Estimator is only available for products which can be added to the shopping basket.


Possible delivery methods: Australia Wide Regular, Australia Wide Express, Air Mail International, Express Post International, Click & Collect

Eyebright, Euphrasia officinalis

Tinctures and Pellets (pure sugar globules) of Eyebright, Euphrasia officinalis.  prepared by the principles of manual dilutions and succussion of classical homeopathy. 

Homeopathic medicines provoke the safest natural stimulation of the defence systems of the body and have no contraindications, adverse drug reactions and carry no risk of drug interactions.

All Newton's homeopathic products are made from pharmaceutical grade raw materials, including pure ethanol and sugar globules (size 50), and are true to name and potency.

Recommended Dose: For indications and dosage, please refer to your homeopathic practitioner or Materia Medica.

Traditional Use: Eyebright has been used in Europe for centuries as a traditional medicine for treatment of various diseases. Decoctions and infusions of flowering aerial parts are used against dry cough, hoarseness, symptomatic treatment of cold, earache, and headache, hay fever, purulent skin lesion, or catarrhal diseases of the intestinal tract, but especially as eyewash to treat and prevent eye disorders such as conjunctivitis, blepharitis, eye fatigue, purulent ocular inflammation, and sties.

Evidence-based Studies: Recent studies indicate that Eyebright contains compounds of particular benefit to the eyes.The therapeutic effect of Eyebright can be attributed mainly to its antioxidant, anti-inflammatory, and antimicrobial activity. Eyebright tightens the mucous membranes of the eye and relieves the inflammation of conjunctivitis and blepharitis. Its ability to counter mucus means that eyebright is often used for infectious and allergic conditions affecting the eyes, middle ear, sinuses, and nasal passages.

References:

European Medicines Agency. Assessment Report on Euphrasia officinalis L. and Euphrasia rostkoviana Hayne, Herba. London, UK: European Medicines Agency; 2010. (A Report of Committee on Herbal Medicinal Products). http://www.ema.europa.eu/docs/en_GB/document_library/Herbal_-_HMPC_assessment_report/2011/01/WC500100385.pdf.

Darshan S., Doreswamy R. Patented anti-inflammatory plant drug development from traditional medicine. Phytotherapy Research. 2004;18(5):343–357. doi: 10.1002/ptr.1475. [PubMed]

Browse this category: Homeopathy